NCT06166355

Brief Summary

The age of onset of anorexia nervosa has been progressively decreasing in recent years. Also, the prevalence rates of childhood anorexia in many countries have grown significantly. This increase was already observed before the COVID-19 pandemic, but the confinements and the stress derived from them have caused this increase to accelerate. As in adolescent and adult patients, in childhood anorexia some of the core signs and symptoms are an extreme fear of gaining weight and avoidance of food. The consequences of the early-onset of anorexia can be very important since the maturation of the organism is more incomplete in children than in adolescents. Weight loss can have very severe consequences, since in children the percentage of body fat is lower. On the other hand, hormonal disorders derived from food deprivation also have very severe consequences for the development of different organs. General physical development and growth can be affected, with consequences such as not being able to reach normal height. The research carried out to date on the efficacy of treatments for childhood anorexia is very scarce. There are no specific treatment strategies or settings for children with anorexia, and little research has been done to tailor treatment for younger patients. Given the need to explore new treatments for anorexia nervosa specifically aimed at children, the objective of this project is to develop a program to carry out exposure to one's own body through virtual reality, gradually, with progressive increases in size until achieving a healthy weight. In the virtual exposure, patients will observe the image of an avatar in a mirror for the time necessary in each session to produce the reduction of the anxiety response. The avatars that will be developed for this purpose will have a physical constitution corresponding to children under 14 years of age, and physical proportions equivalent to those of each patient. The positive results obtained with a previous version of this treatment originally developed for adolescents and adults suggest that its adaptation to children can open new ways for exploring effective treatments for childhood anorexia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2024Dec 2026

First Submitted

Initial submission to the registry

December 4, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

2.5 years

First QC Date

December 4, 2023

Last Update Submit

April 27, 2026

Conditions

Keywords

Attentional BiasVirtual RealityEye-TrackingBody exposure procedureAttentional bias modification training

Outcome Measures

Primary Outcomes (3)

  • Change in Eating Disorder symptomatology: Eating Disorders Inventory-3 (EDI-3; Garner, 2004) drive for thinness (EDI-DT) scale

    Evaluation of the change in drive for thinness, with maximum possible score of 28, where higher scores indicate higher drive for thinness.

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  • Change in Eating Disorder symptomatology: Eating Disorders Inventory-3 (EDI-3; Garner, 2004) body dissatisfaction (EDI-BD) scale

    Evaluation of the change in body dissatisfaction, with maximum possible score of 40, where higher scores indicate higher body dissatisfaction.

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  • Change in body mass index values

    Evaluation of change in Body Mass Index values

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

Secondary Outcomes (6)

  • Change in Body Anxiety: Physical Appearance State Anxiety Scale (PASTAS)

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  • Change in Body image disturbance: Body Appreciation Scale (BAS)

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  • Change in Body image disturbance: Figural Drawing Scale for Body Image Assessment (BIAS-BD) body distortion scores

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  • Change in Body image disturbance: Figural Drawing Scale for Body Image Assessment (BIAS-BD) body dissatisfaction scores

    From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up

  • Change in complete fixation time of the gaze towards weight-related body parts

    From pre-assessment to post-assessment after 6 weeks

  • +1 more secondary outcomes

Other Outcomes (3)

  • Body-related anxiety

    Up to 40 minutes. Baseline (prior to beginning the body exposure session), every two minutes during the exposure, and at the end of the body exposure session

  • Fear of gaining weight

    Up to 40 minutes. Baseline (prior to beginning the body exposure session) and at the end of the body exposure session

  • Full body ownership illusion

    Up to 40 minutes. Baseline (prior to beginning the body exposure session) and at the end of the body exposure session

Study Arms (3)

Cognitive-behavioral therapy plus VR-based body exposure and Attentional Bias Modification Training.

EXPERIMENTAL

In this group, five sessions of VRE will be added to the usual CBT, as in the other experimental group, but, in addition, at the beginning of each of the exposure sessions, the training aimed at reducing the attentional bias will be carried out. The training will be developed through the visual selection of geometric figures that fit approximately with specific parts of the body. Each of these figures can have different colors. Specifically, the patient must detect and identify the figures that will appear in different parts of the avatar's body. In half of the trials, the shape of the figure must be discriminated and in the remaining 50%, the discrimination will be based on color. Throughout the training, the geometric figures will appear on weight-related body parts in 45% of the trials, and in another 45% of the trials, it will appear on non-weight-related body parts. In the remaining trials (10%), the test will appear on one of three neutral stimuli located next to the avatar.

Behavioral: Attentional Bias Modification TrainingBehavioral: VR-based body exposureBehavioral: Cognitive-behavioral therapy

Cognitive-behavioral therapy for anorexia and VR-based body exposure:

EXPERIMENTAL

Patients assigned to this group will receive the usual CBT from the clinical unit or the hospital where they are, and additionally, five sessions of VR-based body exposure intervention. In these weekly sessions patients will go through a body exposure intervention in which they will own a virtual avatar with their real measurements, that will progressively increase its BMI values throughout the following exposure sessions until a healthy BMI value is reached.

Behavioral: VR-based body exposureBehavioral: Cognitive-behavioral therapy

Cognitive behavioral therapy

ACTIVE COMPARATOR

Patients assigned to this group will receive the usual treatment from the center in which they are recruited for the study (CBT), and will have to complete the evaluations following the same schedule as the experimental group.

Behavioral: Cognitive-behavioral therapy

Interventions

Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions and five sessions of Attentional Bias Modification Training.

Cognitive-behavioral therapy plus VR-based body exposure and Attentional Bias Modification Training.

Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions

Cognitive-behavioral therapy for anorexia and VR-based body exposure:Cognitive-behavioral therapy plus VR-based body exposure and Attentional Bias Modification Training.

Usual cognitive-behavioral treatment (CBT) sessions.

Cognitive behavioral therapyCognitive-behavioral therapy for anorexia and VR-based body exposure:Cognitive-behavioral therapy plus VR-based body exposure and Attentional Bias Modification Training.

Eligibility Criteria

AgeUp to 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients with a primary diagnosis of anorexia nervosa (DSM-V)
  • Patients below 14 years old
  • Patients with BMI \<18.5
  • Subsyndromal patients will also be included

You may not qualify if:

  • Visual deficits
  • Epilepsy or neuroleptic medication
  • Psychotic disorder
  • Bipolar disorder
  • Medical complications
  • Pregnancy
  • Clinical cardiac arrhythmia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Sant Joan de Déu

Barcelona, Barcelona, 08950, Spain

RECRUITING

MeSH Terms

Conditions

Anorexia Nervosa

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • José Gutiérrez-Maldonado

    University of Barcelona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

José Gutiérrez-Maldonado

CONTACT

Marta Ferrer-Garcia

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 4, 2023

First Posted

December 12, 2023

Study Start

July 1, 2024

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

The data presented in this study will be available on request from the corresponding author. The data are not publicly available due to patients' privacy restrictions.

Locations